|
|
Volumn 471, Issue 7339, 2011, Pages 428-432
|
|
Cancer: Missing the mark
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BRCA1 PROTEIN;
BRCA2 PROTEIN;
CA 125 ANTIGEN;
MACROPHAGE MIGRATION INHIBITION FACTOR;
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
BIOCHEMISTRY;
BIOMARKER;
BLOOD;
CANCER;
CYTOLOGY;
MOLECULAR ANALYSIS;
ARTICLE;
BLOOD SAMPLING;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER EPIDEMIOLOGY;
CANCER GENETICS;
CANCER GROWTH;
CANCER PATIENT;
CANCER RECURRENCE;
CANCER RESEARCH;
CANCER SCREENING;
CANCER STAGING;
CANCER TEST;
COLORECTAL CANCER;
DIAGNOSTIC ERROR;
EARLY DIAGNOSIS;
FOLLOW UP;
HIGH RISK POPULATION;
HUMAN;
LUNG CANCER;
MAMMOGRAPHY;
MEDICAL RESEARCH;
ONCOLOGY;
OVARY CANCER;
PREDICTION;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEOMICS;
TUMOR SUPPRESSOR GENE;
ALGORITHMS;
CA-125 ANTIGEN;
CLINICAL TRIALS AS TOPIC;
EARLY DETECTION OF CANCER;
FEMALE;
GENE EXPRESSION PROFILING;
HUMANS;
MALE;
MODELS, STATISTICAL;
OVARIAN NEOPLASMS;
PREDICTIVE VALUE OF TESTS;
REPRODUCIBILITY OF RESULTS;
TUMOR MARKERS, BIOLOGICAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 79953032990
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/471428a Document Type: Article |
|
Times cited : (61)
|
|
References (13)
|
